Curcumin Chemoprevention of Colorectal Neoplasia
Interventional
Endpoint Classification: Pharmacodynamics Study, Intervention Model: Single Group Assignment, Masking: Open Label
Gene expression
Change in gene expression
30 days
No
Gary N Asher, MD, MPH
Principal Investigator
University of North Carolina, Chapel Hill
United States: Food and Drug Administration
10-1524
NCT01333917
November 2010
January 2013
Name | Location |
---|---|
UNC Department of Family Medicine | Chapel Hill, North Carolina 27599 |